| Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models Y Yamashita-Kashima, S Iijima, K Yorozu, K Furugaki, M Kurasawa, ... Clinical Cancer Research 17 (15), 5060-5070, 2011 | 212 | 2011 |
| Conformationally Restricted Analogs of 1α,25-Dihydroxyvitamin D3 and Its 20-Epimer: Compounds for Study of the Three-Dimensional Structure of Vitamin D … K Yamamoto, WY Sun, M Ohta, K Hamada, HF DeLuca, S Yamada Journal of medicinal chemistry 39 (14), 2727-2737, 1996 | 87 | 1996 |
| Conformation− function relationship of vitamin D: conformational analysis predicts potential side-chain structure S Yamada, K Yamamoto, H Masuno, M Ohta Journal of medicinal chemistry 41 (9), 1467-1475, 1998 | 76 | 1998 |
| kGCN: a graph-based deep learning framework for chemical structures R Kojima, S Ishida, M Ohta, H Iwata, T Honma, Y Okuno Journal of Cheminformatics 12, 1-10, 2020 | 67 | 2020 |
| Three-dimensional structure-activity relationships and receptor mapping of N1-substituents of quinolone antibacterials M Ohta, H Koga Journal of medicinal chemistry 34 (1), 131-139, 1991 | 66 | 1991 |
| Imidazolidine derivatives K Tachibana, H Sato, M Ohta, M Nakamura, T Shiraishi, I Imaoka, ... US Patent 7,271,188, 2007 | 41 | 2007 |
| Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer H Yoshino, H Sato, T Shiraishi, K Tachibana, T Emura, A Honma, ... Bioorganic & medicinal chemistry 18 (23), 8150-8157, 2010 | 38 | 2010 |
| Design of potent K+ channel openers by pharmacophore model H Koga, M Ohta, H Sato, T Ishizawa, N Hiroyuki Bioorganic & Medicinal Chemistry Letters 3 (4), 625-631, 1993 | 38 | 1993 |
| Imidazolidine derivatives K Tachibana, H Sato, M Ohta, M Nakamura, T Shiraishi, I Imaoka, ... US Patent 7,803,826, 2010 | 35 | 2010 |
| Discovery of an orally-active nonsteroidal androgen receptor pure antagonist and the structure–activity relationships of its derivatives K Tachibana, I Imaoka, T Shiraishi, H Yoshino, M Nakamura, M Ohta, ... Chemical and Pharmaceutical Bulletin 56 (11), 1555-1561, 2008 | 31 | 2008 |
| Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2) YH Han, Y Kato, M Haramura, M Ohta, H Matsuoka, Y Sugiyama Pharmaceutical research 18, 579-586, 2001 | 30 | 2001 |
| On the side chain conformation of 1α, 25-dihydroxyvitamin D3 responsible for binding to the receptor K Yamamoto, M Ohta, HF DeLuca, S Yamada Bioorganic & Medicinal Chemistry Letters 5 (9), 979-984, 1995 | 26 | 1995 |
| High-precision atomic charge prediction for protein systems using fragment molecular orbital calculation and machine learning K Kato, T Masuda, C Watanabe, N Miyagawa, H Mizouchi, S Nagase, ... Journal of Chemical Information and Modeling 60 (7), 3361-3368, 2020 | 25 | 2020 |
| Imidazolidine derivative and use thereof K Tachibana, H Sato, M Ohta, M Nakamura, T Shiraishi, H Yoshino, ... US Patent 8,470,829, 2013 | 24 | 2013 |
| Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination T Shiraishi, S Kadono, M Haramura, H Kodama, Y Ono, H Iikura, T Esaki, ... Bioorganic & medicinal chemistry letters 18 (16), 4533-4537, 2008 | 23 | 2008 |
| Structure–activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists H Yoshino, H Sato, K Tachibana, T Shiraishi, M Nakamura, M Ohta, ... Bioorganic & medicinal chemistry 18 (9), 3159-3168, 2010 | 20 | 2010 |
| Discovery of 7α-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure–activity relationships K Tachibana, I Imaoka, H Yoshino, T Emura, H Kodama, Y Furuta, N Kato, ... Bioorganic & Medicinal Chemistry 15 (1), 174-185, 2007 | 19 | 2007 |
| Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor S Kadono, A Sakamoto, Y Kikuchi, M Oh-eda, N Yabuta, K Yoshihashi, ... Biochemical and biophysical research communications 327 (2), 589-596, 2005 | 19 | 2005 |
| Lead optimization and avoidance of reactive metabolite leading to PCO371, a potent, selective, and orally available human parathyroid hormone receptor 1 (hPTHR1) agonist Y Nishimura, T Esaki, Y Isshiki, Y Furuta, A Mizutani, T Kotake, T Emura, ... Journal of Medicinal Chemistry 63 (10), 5089-5099, 2020 | 17 | 2020 |
| Structure-activity relationships of 6-substituted benzopyran-4-carbothioamide potassium channel openers T Ishizawa, H Koga, M Ohta, H Sato, T Makino, K Kuromaru, N Taka, ... Bioorganic & Medicinal Chemistry Letters 3 (8), 1659-1662, 1993 | 17 | 1993 |
